event,time
46 years old, 0\
    male , 0\
    arterial hypertension , -672\
    obesity , -672\
    admitted , 0\
    fever , 0\
    hypotension , 0\
    marked asthenia , 0\
    cardiological examination , -672\
    electrocardiogram (ECG) , -672\
    transthoracic echocardiography (TTE) , -672\
    hypertension follow-up , -672\
    normal findings , -672\
    COVID-19 infection , -336\
    rhinitis , -336\
    mild cough , -336\
    alert , 0\
    oriented , 0\
    cooperative , 0\
    asthenic , 0\
    blood pressure (BP) 85/55 mmHg , 0\
    heart rate (HR) 120 bpm , 0\
    arterial oxygen saturation 85% , 0\
    fever 38.3°C , 0\
    femoral central venous catheter (CVC) placement , 0\
    ECG sinus tachycardia 122 bpm , 0\
    diffuse low voltages , 0\
    absence of significant repolarization abnormalities , 0\
    neutrophilic leukocytosis , 0\
    white blood cell count 26800 x 1000/mm³ , 0\
    C-reactive protein (CRP) 17.4 mg/dl , 0\
    Procalcitonin 11.7 ng/ml , 0\
    high sensitivity Troponin (hs-Tn) 23000 ng/L , 0\
    brain natriuretic peptide (BNP) 6890 pg/ml , 0\
    creatinine 1.8 mg/dl , 0\
    transaminases elevation , 0\
    total bilirubin elevation , 0\
    RT-PCR nasopharyngeal swab negative , 0\
    COVID-19 IgM high levels , 0\
    TTE normal LV cavitary dimensions , 0\
    indexed end-diastolic volume (EDVi) 41 ml/m² , 0\
    diffuse LV parietal thickening 15-16 mm , 0\
    increased myocardial echogenicity , 0\
    severely reduced LV global systolic function , 0\
    ejection fraction (EF) 26% , 0\
    dP/dT ratio 672 mmHg/sec , 0\
    indexed stroke volume (SVi) 11 ml/m² , 0\
    cardiac index (CI) 1.3 l/min/m² , 0\
    low output , 0\
    grade II LV diastolic dysfunction , 0\
    normal RV cavitary dimensions , 0\
    reduced RV global systolic function , 0\
    RV basal EDD 37 mm , 0\
    RV mid EDD 28 mm , 0\
    TAPSE 14 mm , 0\
    tricuspid S-wave velocity 7.3 cm/sec , 0\
    IVC dilated 26 mm , 0\
    inspiratory collapse <50% , 0\
    RVSP 41 mmHg , 0\
    absence of hemodynamically significant valvulopathy , 0\
    slight pericardial effusion , 0\
    thoracic CT perivascular aortic and pulmonary adipose tissue imbibition , 0\
    abdominal ultrasonography no significant findings , 0\
    blood cultures initiated , 0\
    broad-spectrum antibiotic therapy , 0\
    INN-daptomycin , 0\
    piperacillin/tazobactam , 0\
    crystalloid hydration , 0\
    nasal cannula oxygen 4 l/min , 0\
    norepinephrine 0.6 mcg/kg/min , 0\
    poor hemodynamic response , 0\
    norepinephrine increased to 0.9 mcg/kg/min , 0\
    BP 90-95/60 mmHg , 0\
    oliguria , 0\
    levosimendan initiated , 0\
    levosimendan 0.1 mcg/kg/min , 0\
    BP 100/60 mmHg at 12 hours , 12\
    HR 110 bpm at 12 hours , 12\
    BP 125/70 mmHg at 24 hours , 24\
    HR 95 bpm at 24 hours , 24\
    diuresis 1800 ml , 24\
    TTE control at 12 hours , 12\
    TTE control at 24 hours , 24\
    LV EF 66% at 24 hours , 24\
    dP/dT ratio 1275 mmHg/sec at 24 hours , 24\
    TAPSE 23 mm at 24 hours , 24\
    tricuspid S-wave velocity 11.2 cm/sec at 24 hours , 24\
    SVi 27 ml/m² at 24 hours , 24\
    CI 2.5 l/min/m² at 24 hours , 24\
    LV diastolic function normal at 24 hours , 24\
    IVC diameter 18 mm at 24 hours , 24\
    IVC complete collapse at 24 hours , 24\
    RVSP 28 mmHg at 24 hours , 24\
    blood culture results negative , 0\
    CVC removed , 24\
    CVC tip culture negative , 24\
    cardiac magnetic resonance imaging (CMR) , 24\
    SSFp-CINE sequences normal LV and RV volumes , 24\
    mild hypokinesia of LV lateral and inferolateral walls , 24\
    TIR/T2w increased signal intensity , 24\
    myocardial edema , 24\
    subendocardial localization , 24\
    EGE enhancement , 24\
    LGE enhancement , 24\
    RV free wall edema , 24\
    pericardium edema , 24\
    CMR compatible with immune-mediated myocarditis , 24\
    endomyocardial biopsy , 48\
    lymphocytic myocarditis , 48\
    coronary arteriography normal , 48\
    discharge after 21 days , 504\
    TTE at 1 month post-discharge , 720\
    TTE at 3 months post-discharge , 2160\
    normal hemodynamic compensation , 504\
    normal laboratory findings , 504\
    normal ECG findings , 504\
    normal echocardiographic findings , 504\
    negative blood cultures , 0\
    negative CVC tip culture , 24\
    no substantial inflammation index changes , 24\
    no LV/RV volume changes , 24\
    persistent myocardial inflammation signs , 24\
    absence of ischemic repolarization changes , 0\
    no new Q waves , 0\
    gradual ECG normalization , 24\
